Syra Health wins a training contract from the Sedgwick County Health Department in Kansas to combat substance abuse

KARMEL, Ind., April 22, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health“or the “Company”), a healthcare technology company with a mission to improve healthcare by delivering innovative services and technology solutions, today announced that it has been awarded a five-year contract by the Sedgwick County Health Department in Kansas. As part of the agreement Syra Health will provide Overdose Data to Action (OD2A) training to first responders and faith-based community organizations in Sedgwick County.

Syra Health - A catalyst for improving health outcomes.  (PRNewsfoto/Syra Health)

The training provided by Syra Health will include education on substance use disorders (SUD), harm reduction, overdose trends, naloxone use and treatment options. Additionally, the training will cover linkage to care, offering techniques and strategies for first responders to guide individuals to the appropriate resources. The training will also address stigma and its impact on individuals with addiction, providing insight into how stigmatizing behavior and language can negatively impact these individuals and ways to mitigate such effects.

According to 2023 data from the nonprofit Mental Health America, 15.35% of adults in America reported having a substance use disorder in the past year. Of those reporting a substance use disorder, 93.5% were not receiving any form of treatment.

‘We are privileged to work with Sedgwick County to provide comprehensive and effective training to first responders and faith-based community organizations,” said Dr. Deepika VuppalanchiDIRECTOR, Syra Health. “Our training is critical to supporting individuals with substance use disorders and promoting health outcomes for the community.”


Syra Health is a healthcare technology company tackling some of healthcare’s most important challenges in areas such as behavioral and mental health, digital health and public health, by providing innovative services and technology solutions. from Syra Health products and services are focused on prevention, improved access and affordable care. Syra Health delivers its solutions to payers, providers, life sciences organizations, academic institutions and the government. For more information, please visit


Statements in this press release about future expectations, plans and prospects, as well as any other statements about matters that are not historical facts, may be “forward-looking statements.” These statements include, but are not limited to, statements regarding the expected use of proceeds, the Company’s operations and business strategy and the Company’s expected financial results. The words ‘anticipate’, ‘believe’, ‘continue’, ‘may’, ‘estimate’, ‘expect’, ‘intend’, ‘may’, ‘plan’, ‘potential’, ‘predict’, ‘project ‘”would”, “target”, “will”, “could” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements in this press release are based on management’s current expectations and are subject to significant risk, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our year-end Form 10-K December 31, 2023 and other periodic reports submitted to the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information please contact:

For media inquiries:
Christine DruryDirector of Communications and Marketing
Syra Health
(email protected)

For investor questions:
Ben ShamsianDeputy Director
Lytham Partners, LLC
(email protected)

Cisie View original content to download multimedia: substance -use disorder-302122957.html

SOURCE Syra Health